rho-Associated, Coiled-Coil Containing Protein Kinase 1 (ROCK1) (AA 1114-1126), (cleaved) antibody

Details for Product No. ABIN121298
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

 
Antigen
Synonyms P160ROCK, ROCK-I, 1110055K06Rik, Rock-I, P160Rock, p160ROCK, LOC100229794, CG9774, DROK, DRhk, DRok, Dmel\\CG9774, Drok, ROCK, ROCK-1, ROCK1, ROK, ROKalpha/beta, Rhk, RhoK, Rock, Rok, dROK, dRok, drok
Epitope
AA 1114-1126, cleaved
(12), (12), (9), (5), (3), (3), (2), (2), (1), (1), (1), (1), (1), (1)
Reactivity
Dog (Canine), Human, Monkey, Mouse (Murine), Rabbit, Rat (Rattus)
(79), (48), (48), (12), (12), (3)
Host
Mouse
(68), (14)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2)
Application
Western Blotting (WB)
(60), (29), (20), (14), (9), (6), (4), (2)
Pubmed 2 references available
Catalog no. ABIN121298
Quantity 0.1 mg
Price
456.50 $   Plus shipping costs $45.00
Shipping to United States (Change)
Availability Discontinued
Add to Basket

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Synthetic peptide sequence corresponding to amino acids 1114-1126 of human ROCK-1 AA Sequence:GNLPESRIEGWLS
Clone 154C1465
Isotype IgG
Purification Protein G Chromatography
Alternative Name ROCK1
Background The Rho target protein, Rho-associated coiled coil-containing protein kinase (ROCK)-1 has been found to be a new Caspase-3 substrate. ROCK, one of the effectors of the small GTPase Rho, has recently been shown to contribute significantly to myosin light chain (MLC) activation through two pathways: direct phosphorylation of MLC and phosphorylation of MLC phosphatase, leading to its inhibition. The increase in cellular contractility that is necessary for apoptotic membrane blebbing implies sustained augmentation of MLC phosphorylation. ROCK-1 consists of an amino-terminal kinase domain and an inhibitory cysteine/histidine-rich C-terminal domain that is located within a pleckstrin-homology region. They are joined by a variable region that contains the Rho-binding domain. During apoptosis, ROCK-I is cleaved by caspase-3 at a conserved DETD1113/G sequence and its carboxy-terminal inhibitory domain is removed, resulting in deregulated and constitutive kinase activity. The caspase-3-mediated cleavage and activation of ROCK I induces phosphorylation of MLC and membrane blebbing, one of the first events in the execution phase of apoptosis.
UniProt Q13464
Research Area Cancer, Cell Cycle, Cytoskeleton, Microfilaments, Apoptosis/Necrosis, Signaling
Application Notes Western blot: 1 - 2 ug/ml. Recommended Positive Control: camptothecin treated or anti-Fas treated Jurkat (10 ng/ml, 2 hr). Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer PBS containing 0.2 % gelatin and 0.05 % sodium azide
Preservative Sodium azide
Storage 4 °C/-20 °C
Storage Comment Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing. Shelf Life: one year from despatch.
Expiry Date 12 months
Supplier Images
anti-rho-Associated, Coiled-Coil Containing Protein Kinase 1 (ROCK1) (AA 1114-1126), (cleaved) antibody Detection of cleaved ROCK-1 in apoptotic Jurkat cell lysates (10 ug/lane). Lane 1. Jurkat cells were treated with camptothecin. Lane 2. Jurkat cells were treated with anti-Fas antibody (10 ng/ml for 2 hrs). ABIN121298 was used at a concentration of 1 ug/ml.
General Amano, Ito, Kimura et al.: "Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase)." in: The Journal of biological chemistry, Vol. 271, Issue 34, pp. 20246-9, 1996 (PubMed).

Sebbagh, Renvoize, Hamelin et al.: "Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing." in: Nature cell biology, Vol. 3, Issue 4, pp. 346-52, 2001 (PubMed).

Hosts (68), (14)
Reactivities (79), (48), (48), (12), (12), (3)
Applications (60), (29), (20), (14), (9), (6), (4), (2)
Conjugates (2), (2), (2), (2), (2), (2), (2), (2), (2), (2), (2)
Epitopes (12), (12), (9), (5), (3), (3), (2), (2), (1), (1), (1), (1), (1), (1)
back to top